Search

everythinglearnresearchcommunity

for

Search:↓

Exosomes from hair papilla cells and the Chinese medicine Liao Tuo Fang can potentially promote hair growth and could be used to develop hair growth drugs.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Combining light therapy with certain substances improves hair growth in people with hair loss.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

The document's conclusion cannot be provided because the content is not accessible.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Dual wavelength LEDs may help reduce hair loss by lowering DHT levels.

The treatment was not recommended due to limited effectiveness and significant side effects.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

A Turkish woman has a hair condition caused by a LIPH gene mutation.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

Laser therapy and acupuncture helped regrow hair in a patient.

The biofilm enhances skin healing by promoting cell growth and blood vessel formation.

Tick bites can cause localized hair loss.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

ILC1-like cells can independently cause alopecia areata.

Low level laser therapy is effective and safe for various skin and hair conditions.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Low-level light therapy may reduce hair loss and improve hair quality but it's unclear who benefits most.

The light-guiding microneedle patch effectively stimulates hair growth in androgenetic alopecia without serious side effects.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.